Physician profile
Abed E Dehnee
NPI 1285778472
$8,364.35
in general payments reported to CMS, 2019-2025
37 companies · $2,958 in 2025
The $2,958 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $807 · 2021: $973 · 2022: $1,094 · 2023: $922 · 2024: $1,233 · 2025: $2,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,412 · Travel and Lodging: $1,701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,412.31 |
| Travel and Lodging | $1,701.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,207.45 | 2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $715.40 | 2019-2024 | |
| Ge Healthcare | $642.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $479.98 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $435.92 | 2019-2024 | Farxiga |
| Pfizer INC. | $414.21 | 2019-2025 | |
| Boston Scientific Corporation | $386.83 | 2019-2025 | General - Balloon Catheters, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $348.05 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $337.44 | 2020-2024 | Impella |
| Medtronic, INC. | $254.33 | 2023-2025 | Endurant Iis, Pulseselect, Claria Mri Quad Crt-D Surescan |
| Abbott Laboratories | $246.54 | 2023-2025 | Diamondback Coronary, Esprit, Diamondback Peripheral |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $220.48 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $187.73 | 2023-2025 | Verquvo |
| Philips North America LLC | $145.37 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.05 | 2022-2023 | Jardiance |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $124.93 | 2024 | Kengreal |
| Siemens Medical Solutions USA, INC. | $123.28 | 2021 | |
| Alnylam Pharmaceuticals INC. | $109.71 | 2021-2022 | |
| Shockwave Medical, INC | $108.47 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $93.68 | 2020-2025 | Repatha, Repatha |
| Novo Nordisk INC | $88.27 | 2024-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $77.54 | 2021-2022 | |
| Cardiva Medical, INC. | $55.27 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Kiniksa Pharmaceuticals, LTD. | $50.61 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $49.91 | 2024 | Arcalyst |
| Cardiovascular Systems INC. | $47.14 | 2019-2023 | Diamondback Coronary |
| Cordis US Corp. | $36.83 | 2025 | Mynx Control Venous |
| Kestra Medical Technology Services, INC. | $36.69 | 2022 | |
| Imperative Care, INC | $31.82 | 2024 | Symphony Catheter |
| Stryker Corporation | $29.47 | 2025 | Artix Mt |
| Angiodynamics, INC. | $28.49 | 2025 | Alphavac |
| Teleflex LLC | $24.93 | 2024 | Arrow |
| Becton, Dickinson and Company | $18.65 | 2025 | Rotarexs 6 F X 135 Cm |
| Atricure, INC. | $18.05 | 2024 | |
| Surmodics, INC. | $16.41 | 2024 | Pounce Venous Thrombectomy System |
| Portola Pharmaceuticals, LLC | $15.93 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abed Dehnee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.